Press Releases
Stay informed with the latest updates from Roquette. Our press release resource provides timely announcements on new product launches, innovative excipient technologies, regulatory approvals, company news and much more. Explore our archive to discover breakthroughs in excipients, capsules and APIs that are driving the evolution of healthcare.

Filter
Pharma
Published May 09, 2023
PEARLITOL® ProTec, a new excipient for the stability of probiotic supplements
Roquette Spotlights Stability in Probiotic Supplements with Launch of New Excipient PEARLITOL® ProTec Co-Processed Mannitol-Starch at Vitafoods Europe 2023
Pharma
Published April 19, 2023
$25 Million Pharmaceutical Innovation Center in the USA
Roquette celebrates the grand opening of its new Pharmaceutical Innovation Center, located near Philadelphia, Pennsylvania, right in the heart of the United States’ Northeastern pharmaceutical corridor.
Pharma
Published November 01, 2022
Launch of Next-Generation Direct Compression Solutions
CPHI Frankfurt 2022: New PEARLITOL® CR-H mannitol and PEARLITOL® 200 GT mannitol are unveiled. Join the Roquette team on stand 80C90 (Excipient Gold area) to discover the latest innovations in direct compression technology, designed to overcome unique drug formulation challenges and support expansion into novel application areas.
Corporate
Published September 20, 2022
Roquette Finalizes Complete Acquisition of Crest Cellulose
Roquette today announces its complete acquisition of India-based excipient manufacturer, Crest Cellulose.
Pharma
Published July 05, 2022
Roquette expands PEARLITOL® SD mannitol range for APIs
Developed specifically for active pharmaceutical ingredients (APIs) that are highly sensitive to reducing sugars, PEARLITOL® 150 SD supports opportunities to unlock advanced tablet dosage forms – even when using challenging active ingredients.
Pharma
Published February 28, 2022
Cell therapy acceleration strategy - OPTI-STEM project
The OPTI-STEM project aims to optimize the production of MSCs in order to democratize access to them and thus allow the diversification of therapeutic applications of this type of cells and their derivatives (exosomes, etc.).
Pharma
Published December 07, 2021
Roquette Reveals New US-Based Pharmaceutical Innovation Center
The group accelerates its pharmaceutical business expansion in the Americas to consolidate its global leadership position and reinforce its commitment to customer-focused innovation.
Pharma
Published November 09, 2021
New Ready-to-Use LYCAGEL® PREMIX for Plant-Based Softgel Offering With
Unlock nature’s potential with LYCAGEL® PREMIX – a new easy-to-use plant-based softgel blend for nutraceutical and pharmaceutical applications.
Pharma
Published June 29, 2021
Roquette Launches a New Digital Pharma Marketplace
Roquette announces the opening of its new pharma online marketplace, powered by Knowde. The e-commerce platform will provide users with access to Roquette’s trusted and reliable flagship pharmaceutical and biopharmaceutical offering at smaller quantities for the first time.
Pharma
Published March 11, 2021
Collaboration Delpharm-Roquette: softgel plant-based shell capsule
Delpharm Evreux, in collaboration with Roquette, has successfully scaled and qualified a new softgel capsule with a plant-based shell.
Pharma
Published November 18, 2020
Innovative Plant-Based Solution for Veggie Softgel Market
Innovative Plant-Based Solution Unlocks Possibilities for Veggie Softgel Market: Market-first plant-based softgel system provides a strong alternative to gelatin for nutraceutical and pharmaceutical manufacturers and marketers of softgel products.